PBS to List Tepezza for Thyroid Eye Disease
Eligible adults with active moderate to severe Thyroid Eye Disease will gain Pharmaceutical Benefits Scheme access to the treatment from 1 November 2026.
Live Poll
Should Australia's public drug subsidy scheme cover expensive new treatments for rare diseases?